This announcement is a separate document:
アステラス製薬：無形資産の減損損失 条件付対価に関わる公正価値変動額の計上 通期業績予想の修正について
Astellas Pharma: Revision of full-year earnings forecasts with recorded fair value fluctuations relating to conditional compensation for impairment losses of intangible assets
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.